Susquehanna International Group, LLP Bicycle Therapeutics PLC Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$16.75 - $26.1 $299,825 - $467,190	-17,900 Reduced 66.3%	9,100 $226,000
Q4 2023 Feb 14, 2024	BUY	$13.29 - $22.2 $358,830 - $599,400	27,000 New	27,000 $488,000
Q1 2023 May 16, 2023	BUY	$20.02 - $31.37 $150,150 - $235,275	7,500 Added 70.75%	18,100 $384,000
Q4 2022 Feb 14, 2023	BUY	$20.37 - $32.9 $215,922 - $348,740	10,600 New	10,600 $313,000
Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $982,905 - $3.57 Million	-75,900 Reduced 80.57%	18,300 $307,000
Q1 2022 May 16, 2022	BUY	$40.12 - $59.5 $2.65 Million - $3.93 Million	66,000 Added 234.04%	94,200 $4.13 Million
Q4 2021 Feb 14, 2022	BUY	$41.7 - $61.14 $804,810 - $1.18 Million	19,300 Added 216.85%	28,200 $1.72 Million
Q3 2021 Nov 15, 2021	BUY	$27.95 - $44.24 $248,755 - $393,736	8,900 New	8,900 $370,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $419M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.